{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:13:42Z","timestamp":1783509222006,"version":"3.55.0"},"reference-count":44,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Human group 2 innate lymphoid cells (ILC2s) are key regulators of chronic inflammation in type 2 diabetes mellitus (T2DM). In contrast, autoimmune-mediated inflammation is characteristic of type 1 diabetes mellitus (T1DM), particularly slowly progressive insulin-dependent diabetes mellitus (SPIDDM). However, whether ILC2-mediated inflammation observed in T2DM is also present in SPIDDM remains unclear. We hypothesized that ILC2 profiling could help distinguish T2DM from SPIDDM and aimed to characterize ILC2s in Japanese patients. Peripheral blood mononuclear cells (PBMCs) were obtained from Japanese patients with T1DM or T2DM participating in a diabetic cohort study. Ex vivo flow cytometric immunophenotyping was performed, and innate lymphoid cell fractions were quantified using fluorescence-activated cell sorting (FACS). The frequency of ILC2s was determined by FACS, and ILC2 proliferation was assessed ex vivo in PBMCs exposed to saturated fatty acids mimicking conditions of worsening T2DM. Mean (SD) ILC2 frequencies were 5.50 (2.30) % in T2DM and 3.42 (2.16) % in SPIDDM. Frequencies were significantly higher in T2DM than in SPIDDM (P = 0.0007) and were also elevated compared with other T1DM subtypes. ILC2 proliferation was influenced by saturated fatty acids associated with T2DM progression. This study demonstrated that numerical differences in ILC2s were observed in T2DM but not in SPIDDM.<\/jats:p>","DOI":"10.1530\/joe-25-0426","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:13:23Z","timestamp":1774527203000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":0,"title":["Differences in group 2 innate lymphoid cells in type 2 or slowly progressive insulin-dependent type 1 diabetes mellitus"],"prefix":"10.1530","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3263-9469","authenticated-orcid":true,"given":"Noriyuki","family":"Kitagawa","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Kawai","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Katayama","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Kuramoto","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Yoneda","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7269-1697","authenticated-orcid":true,"given":"Takuro","family":"Okamura","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026070806155412400_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.727008","article-title":"Type 2 innate lymphoid cells: protectors in type 2 diabetes","volume":"12","author":"Painter","year":"2021","journal-title":"Front Immunol"},{"key":"2026070806155412400_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/intimm\/dxv050","article-title":"Group 2 innate lymphoid cells in disease","volume":"28","author":"Halim","year":"2016","journal-title":"Int Immunol"},{"key":"2026070806155412400_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.immuni.2017.10.015","article-title":"Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production","volume":"47","author":"Dalmas","year":"2017","journal-title":"Immunity"},{"key":"2026070806155412400_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"2026070806155412400_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"2026070806155412400_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fimmu.2012.00101","article-title":"Role of innate lymphocytes in infection and inflammation","volume":"3","author":"Koyasu","year":"2012","journal-title":"Front Immunol"},{"key":"2026070806155412400_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coi.2015.01.004","article-title":"Innate lymphoid cells: new insights into function and development","volume":"32","author":"Cortez","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"2026070806155412400_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/nyas.12106","article-title":"Th2-type innate immune responses mediated by natural helper cells","volume":"1283","author":"Koyasu","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"2026070806155412400_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat Immunol"},{"key":"2026070806155412400_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ni.3444","article-title":"IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat Immunol"},{"key":"2026070806155412400_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jdi.14121","article-title":"New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): report from committee on type 1 diabetes of the Japan Diabetes Society (English version)","volume":"15","author":"Shimada","year":"2024","journal-title":"J Diabetes Investig"},{"key":"2026070806155412400_bib12","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2147\/DMSO.S191007","article-title":"Slowly progressive type 1 diabetes mellitus: current knowledge and future perspectives","volume":"12","author":"Nishimura","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2026070806155412400_bib13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/dmrr.1235","article-title":"Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes","volume":"27","author":"Shimada","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"2026070806155412400_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s13300-017-0299-7","article-title":"Possible long-term efficacy of Sitagliptin, a dipeptidyl Peptidase-4 inhibitor, for slowly progressive type 1 diabetes (SPIDDM) in the stage of non-insulin-dependency: an open-label randomized controlled pilot trial (SPAN-S)","volume":"8","author":"Awata","year":"2017","journal-title":"Diabetes Ther"},{"key":"2026070806155412400_bib15","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/dbi20-0017","article-title":"Management of Latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"key":"2026070806155412400_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1507\/endocrj.EJ17-0414","article-title":"Late-night-dinner is associated with poor glycemic control in people with type 2 diabetes: the KAMOGAWA-DM cohort study","volume":"65","author":"Sakai","year":"2018","journal-title":"Endocr J"},{"key":"2026070806155412400_bib17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003","journal-title":"Diabetes Care"},{"key":"2026070806155412400_bib18","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2337\/dc25-0579","article-title":"Rapid and slow progressors toward \u03b2-Cell depletion and their predictors in type 1 diabetes: prospective longitudinal study in Japanese type 1 diabetes (TIDE-J)","volume":"48","author":"Noso","year":"2025","journal-title":"Diabetes Care"},{"key":"2026070806155412400_bib19","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","article-title":"CD4+ group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis","volume":"196","author":"Roan","year":"2016","journal-title":"J Immunol"},{"key":"2026070806155412400_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1074-7613(02)00474-0","article-title":"Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro","volume":"17","author":"Schmitt","year":"2002","journal-title":"Immunity"},{"key":"2026070806155412400_bib21","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1770","article-title":"In vitro differentiation of Murine innate lymphoid cells from common lymphoid progenitor cells","volume":"6","author":"Seehus","year":"2016","journal-title":"Bio Protoc"},{"key":"2026070806155412400_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.immuni.2020.03.003","article-title":"Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation","volume":"52","author":"Karagiannis","year":"2020","journal-title":"Immunity"},{"key":"2026070806155412400_bib23","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20151448","article-title":"Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection","volume":"213","author":"Wilhelm","year":"2016","journal-title":"J Exp Med"},{"key":"2026070806155412400_bib24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41590-021-01043-8","article-title":"Dichotomous metabolic networks govern human ILC2 proliferation and function","volume":"22","author":"Surace","year":"2021","journal-title":"Nat Immunol"},{"key":"2026070806155412400_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648754","article-title":"Group 3 innate lymphoid cells protect steatohepatitis from high-fat diet induced toxicity","volume":"12","author":"Hamaguchi","year":"2021","journal-title":"Front Immunol"},{"key":"2026070806155412400_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669629","article-title":"ILC2s improve glucose metabolism through the control of saturated fatty acid absorption within visceral fat","volume":"12","author":"Okamura","year":"2021","journal-title":"Front Immunol"},{"key":"2026070806155412400_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2015.12.007","article-title":"The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease","volume":"36","author":"Ruiz-N\u00fa\u00f1ez","year":"2016","journal-title":"J Nutr Biochem"},{"key":"2026070806155412400_bib28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/ATVBAHA.117.310581","article-title":"Saturated fatty acids undergo intracellular crystallization and activate the NLRP3 inflammasome in macrophages","volume":"38","author":"Karasawa","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026070806155412400_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"2026070806155412400_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep39884","article-title":"Soluble uric acid activates the NLRP3 inflammasome","volume":"7","author":"Braga","year":"2017","journal-title":"Sci Rep"},{"key":"2026070806155412400_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2023.1193480","article-title":"High-fat diet and palmitic acid amplify airway type 2 inflammation","volume":"4","author":"Dimasuay","year":"2023","journal-title":"Front Allergy"},{"key":"2026070806155412400_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"key":"2026070806155412400_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2014.12.011","article-title":"Activated type 2 innate lymphoid cells regulate beige fat biogenesis","volume":"160","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"2026070806155412400_bib34","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.3390\/nu11112697","article-title":"Effects of duodenal infusion of lauric acid and L-tryptophan, alone and combined, on fasting glucose, insulin and glucagon in healthy men","volume":"11","author":"McVeay","year":"2019","journal-title":"Nutrients"},{"key":"2026070806155412400_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S2213-8587(14)70146-9","article-title":"Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study","volume":"2","author":"Forouhi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070806155412400_bib36","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.5551\/jat.39164","article-title":"Association between serum elaidic acid concentration and insulin resistance in two Japanese cohorts with different lifestyles","volume":"24","author":"Itcho","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"2026070806155412400_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.107084","article-title":"Analysis of islet antigen-specific autoreactive T cells from Japanese patients with slowly progressive insulin-dependent diabetes mellitus","volume":"277","author":"Kitagawa","year":"2026","journal-title":"Immunol Lett"},{"key":"2026070806155412400_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.1700172","article-title":"Single-cell RNA sequencing reveals expanded clones of islet antigen-reactive CD4+ T cells in peripheral blood of subjects with type 1 diabetes","volume":"199","author":"Cerosaletti","year":"2017","journal-title":"J Immunol"},{"key":"2026070806155412400_bib39","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/cells11101623","article-title":"Characterization of peripheral blood TCR in patients with type 1 diabetes mellitus by BD RhapsodyTM VDJ CDR3 assay","volume":"11","author":"Okamura","year":"2022","journal-title":"Cells"},{"key":"2026070806155412400_bib40","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/s41467-024-48833-w","article-title":"Germline-like TCR-\u03b1 chains shared between autoreactive T cells in blood and pancreas","volume":"15","author":"Linsley","year":"2024","journal-title":"Nat Commun"},{"key":"2026070806155412400_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3164\/jcbn.24-86","article-title":"Single-cell analysis reveals islet autoantigen's immune activation in type 1 diabetes patients","volume":"76","author":"Okamura","year":"2025","journal-title":"J Clin Biochem Nutr"},{"key":"2026070806155412400_bib42","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J Clin Investig"},{"key":"2026070806155412400_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaci.2021.04.029","article-title":"Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1","volume":"149","author":"Blanquart","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2026070806155412400_bib44","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/biomedicines10051189","article-title":"Lipidomics analysis of free fatty acids in human plasma of healthy and diabetic subjects by LC-HRMS","volume":"10","author":"Kokotou","year":"2022","journal-title":"Biomedicines"}],"container-title":["Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/269\/3\/JOE-25-0426.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/269\/3\/JOE-25-0426.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-25-0426\/520070\/joe-25-0426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article-pdf\/doi\/10.1530\/JOE-25-0426\/520070\/joe-25-0426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:16:07Z","timestamp":1783505767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/joe\/article\/269\/3\/e250426\/77600\/Differences-in-group-2-innate-lymphoid-cells-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/joe-25-0426","relation":{},"ISSN":["1479-6805","0022-0795"],"issn-type":[{"value":"1479-6805","type":"electronic"},{"value":"0022-0795","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"e250426"}}